Anthony Nolan, London, UK.
Bone Marrow Transplant. 2013 Feb;48(2):210-9. doi: 10.1038/bmt.2012.54. Epub 2012 Apr 9.
The demand for unrelated haematopoietic cell (HPC) donors has risen threefold over the last decade, and is likely to continue to rise over the next 10 years. The time taken from diagnosis to transplant is recognised to adversely affect patient outcome, and provision of unrelated donors (UDs) has been identified as a key source of delay. Obstacles to provision of UD include: delays in referral to a transplant centre, awaiting sibling typing, lack of matched donors (particularly for those from ethnic minorities and/or with rare HLA phenotypes), low- or intermediate-resolution donor HLA typing, donor attrition from the registries, donor ineligibility on grounds of health and difficulties encountered transporting HPC across international borders. There are now over 18 million volunteer donors in registries worldwide, and efficiency has improved, at least in part, because of a switch from paper to electronic searches. As a result, the average time from search request to transplant is estimated to be less than half of what it was two decades ago. Furthermore, registries have developed a number of strategies designed to minimise delays and, ultimately, improve patient outcomes. These include: optimisation of donor numbers and ethnic mix through focused and selective recruitment; high-resolution typing at donor recruitment; cord blood banking with aggressive recruitment in ethnic minorities; early identification of those unlikely to find a match so alternative transplant options may be pursued in a timely manner, through use of HLA-based predictive algorithms; reduction of donor attrition; centralised, registry-based, donor identification services; and provision of a back-up donor.
在过去十年中,对无关造血细胞 (HPC) 供体的需求增加了两倍,并且在未来十年中可能会继续增加。从诊断到移植的时间被认为会对患者的预后产生不利影响,并且已经确定提供无关供体 (UD) 是延迟的关键来源。提供 UD 的障碍包括:向移植中心转介延迟、等待兄弟姐妹配型、缺乏匹配的供体(特别是对于少数民族和/或具有罕见 HLA 表型的人)、低分辨率或中分辨率供体 HLA 分型、供体从注册中心流失、由于健康原因供体不合格以及在跨国界运输 HPC 时遇到的困难。目前,全球有超过 1800 万志愿者在注册中心登记,效率有所提高,至少部分原因是从纸质搜索转向电子搜索。因此,从搜索请求到移植的平均时间估计不到 20 年前的一半。此外,注册中心已经制定了许多旨在尽量减少延迟并最终改善患者预后的策略。这些策略包括:通过有针对性和选择性的招募来优化供体数量和种族构成;在招募时进行高分辨率分型;在少数民族中积极招募脐带血库;通过使用基于 HLA 的预测算法,早期识别那些不太可能找到匹配的人,以便及时采用替代移植选择;减少供体流失;集中、基于注册中心的供体识别服务;以及提供后备供体。